Ruilu Feng

Ms. Ruilu Feng

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2018 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
GZGaozheng Zhao
Gaozheng Zhao
HWHuihui Wu
Huihui Wu
RFRuilu Feng
Ruilu Feng
Dongdong WangDongdong Wang
Dongdong Wang
PXPengping Xu
Pengping Xu
QCQianwang Chen
Qianwang Chen

9 July 2019 in Life
Verified
Journal Article
Open access
PDF file
RNRong Ni
Rong Ni
RFRuilu Feng
Ruilu Feng
YCYing Chau
Ying Chau
The discovery of the genetic roots of various human diseases has motivated the exploration of different exogenous nucleic acids as therapeutic agents to treat these genetic disorders (inherited or acquired). However, the physicochemical properties of nucleic acids render them liable to degradation and also restrict their cellular entrance and gene translation/inhibition at the correct cellular location. Therefore, gene condensation/protection and guided intracellular trafficking are necessary for exogenous nucleic acids to function inside cells. Diversified cationic formulation materials, including natural and synthetic lipids, polymers, and proteins/peptides, have been developed to facilitate the intracellular transportation of exogenous nucleic acids. The chemical properties of different formulation materials determine their special features for nucleic acid delivery, so understanding the property–function correlation of the formulation materials will inspire the development of next-generation gene delivery carriers. Therefore, in this review, we focus on the chemical properties of different types of formulation materials and discuss how these formulation materials function as protectors and cellular pathfinders for nucleic acids, bringing them to their destination by overcoming different cellular barriers.

25 October 2017 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
RZRuirui Zhang
Ruirui Zhang
ZSZhongti Sun
Zhongti Sun
RFRuilu Feng
Ruilu Feng
ZLZhiyu Lin
Zhiyu Lin
HLHaizhen Liu
Haizhen Liu
Qianwang ChenQianwang Chen
Qianwang Chen

23 August 2018 in ACS Omega
Verified
Journal Article
Open access
GZGaozheng Zhao
Gaozheng Zhao
HWHuihui Wu
Huihui Wu
RFRuilu Feng
Ruilu Feng
Dongdong WangDongdong Wang
Dongdong Wang
PXPengping Xu
Pengping Xu
Qianwang ChenQianwang Chen
Qianwang Chen
Zeolitic imidazolate framework-8 (ZIF-8) has received wide attention in recent years as a potential drug vehicle for the treatment of cancer due to its acid-responsiveness and moderate biocompatibility. However, its congenital deficiency of intrinsic imaging capability limits its wider applications; therefore, a postsynthetic exchange approach was utilized to introduce paramagnetic manganese(II) ions into the ZIF-8 matrix. As a result, bimetallic zeolitic imidazolate frameworks (Mn–Zn–ZIF) were thus fabricated and exhibited pH-responsive T1-weighted magnetic resonance imaging (MRI) contrast effect. Remarkably, we also found its own fluorescence derived from 2-methylimidazole, which is the first report of the intrinsic two-photon fluorescence imaging of ZIFs to our knowledge. Mn–Zn–ZIF still preserves the original properties of ZIF-8 of high surface areas, microporosity, and acid sensitivity. After further PEGylation of Mn–Zn–ZIF, the nanoparticles showed no obvious toxicity and its MRI contrast effect has also been enhanced. Our work highlights the promise of modified zeolitic imidazolate frameworks as potential cancer theranostic platforms.


17 February 2023 in ACS Applied Nano Materials
Verified
Journal Article
Open access
RNRong Ni
Rong Ni
RFRuilu Feng
Ruilu Feng
YCYing Chau
Ying Chau